Vascularized Composite Allograft Rejection Is Delayed by Intrajejunal Treatment with Donor Splenocyt...
Vascularized Composite Allograft Rejection Is Delayed by Intrajejunal Treatment with Donor Splenocytes without Concomitant Immunosuppressants
About this item
Full title
Author / Creator
Publisher
Cairo, Egypt: Hindawi Puplishing Corporation
Journal title
Language
English
Formats
Publication information
Publisher
Cairo, Egypt: Hindawi Puplishing Corporation
Subjects
More information
Scope and Contents
Contents
Background. Mucosal or oral tolerance, an established method for inducing low-risk antigen-specific hyporesponsiveness, has not been investigated in vascularized composite allograft (VCA) research. We studied its effects on recipient immune responses and VCA rejection. Methods. Lewis rats (n=12; TREATED) received seven daily intrajejunal treatments...
Alternative Titles
Full title
Vascularized Composite Allograft Rejection Is Delayed by Intrajejunal Treatment with Donor Splenocytes without Concomitant Immunosuppressants
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_1282231027
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_1282231027
Other Identifiers
ISSN
1740-2522,2314-8861
E-ISSN
1740-2530,2314-7156
DOI
10.1155/2012/704063
